Research output: Contribution to journal › Article › peer-review
Prevention of High Glucose-Mediated EMT by Inhibition of Hsp70 Chaperone. / Никотина, Алина Дмитриевна; Владимирова, Снежана Александровна; Комарова, Елена Юрьевна; Алексеев, Дмитрий Александрович; Ефремов, Сергей Михайлович; Леонова, Елизавета Андреевна; Павлов, Ростислав Владимирович; Карцев, Виктор ; Полоник, Cергей ; Маргулис, Борис Александрович; Гужова, Ирина Владимировна.
In: International Journal of Molecular Sciences, Vol. 22, No. 13, 6902, 27.06.2021.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Prevention of High Glucose-Mediated EMT by Inhibition of Hsp70 Chaperone
AU - Никотина, Алина Дмитриевна
AU - Владимирова, Снежана Александровна
AU - Комарова, Елена Юрьевна
AU - Алексеев, Дмитрий Александрович
AU - Ефремов, Сергей Михайлович
AU - Леонова, Елизавета Андреевна
AU - Павлов, Ростислав Владимирович
AU - Карцев, Виктор
AU - Полоник, Cергей
AU - Маргулис, Борис Александрович
AU - Гужова, Ирина Владимировна
N1 - Publisher Copyright: © 2021 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2021/6/27
Y1 - 2021/6/27
N2 - Hyperglycemia may contribute to the progression of carcinomas by triggering epithelial-to-mesenchymal transition (EMT). Some proteostasis systems are involved in metastasis; in this paper, we sought to explore the mechanism of Hsp70 chaperone in EMT. We showed that knockdown of Hsp70 reduced cell migration capacity concomitantly with levels of mRNA of the Slug, Snail, and Twist markers of EMT, in colon cancer cells incubated in high glucose medium. Conversely, treatment of cells with Hsp70 inducer U-133 were found to elevate cell motility, along with the other EMT markers. To prove that inhibiting Hsp70 may reduce EMT efficiency, we treated cells with a CL-43 inhibitor of the HSF1 transcription factor, which lowered Hsp70 and HSF1 content in the control and induced EMT in carcinoma cells. Importantly, CL-43 reduced migration capacity, EMT-linked transcription factors, and increased content of epithelial marker E-cadherin in colon cancer cells of three lines, including one derived from a clinical sample. To prove that Hsp70 chaperone should be targeted when inhibiting the EMT pathway, we treated cancer cells with 2-phenylethynesulfonamide (PES) and demonstrated that the compound inhibited substrate-binding capacity of Hsp70. Furthermore, PES suppressed EMT features, cell motility, and expression of specific transcription factors. In conclusion, the Hsp70 chaperone machine efficiently protects mechanisms of the EMT, and the safe inhibitors of the chaperone are needed to hamper metastasis at its initial stage.
AB - Hyperglycemia may contribute to the progression of carcinomas by triggering epithelial-to-mesenchymal transition (EMT). Some proteostasis systems are involved in metastasis; in this paper, we sought to explore the mechanism of Hsp70 chaperone in EMT. We showed that knockdown of Hsp70 reduced cell migration capacity concomitantly with levels of mRNA of the Slug, Snail, and Twist markers of EMT, in colon cancer cells incubated in high glucose medium. Conversely, treatment of cells with Hsp70 inducer U-133 were found to elevate cell motility, along with the other EMT markers. To prove that inhibiting Hsp70 may reduce EMT efficiency, we treated cells with a CL-43 inhibitor of the HSF1 transcription factor, which lowered Hsp70 and HSF1 content in the control and induced EMT in carcinoma cells. Importantly, CL-43 reduced migration capacity, EMT-linked transcription factors, and increased content of epithelial marker E-cadherin in colon cancer cells of three lines, including one derived from a clinical sample. To prove that Hsp70 chaperone should be targeted when inhibiting the EMT pathway, we treated cancer cells with 2-phenylethynesulfonamide (PES) and demonstrated that the compound inhibited substrate-binding capacity of Hsp70. Furthermore, PES suppressed EMT features, cell motility, and expression of specific transcription factors. In conclusion, the Hsp70 chaperone machine efficiently protects mechanisms of the EMT, and the safe inhibitors of the chaperone are needed to hamper metastasis at its initial stage.
KW - CL-43
KW - Colon cancer
KW - EMT
KW - Hsp70
KW - Hyperglycemia
KW - PES
KW - Humans
KW - Cell Transformation, Neoplastic/genetics
KW - HSP70 Heat-Shock Proteins/metabolism
KW - Blood Glucose
KW - Snail Family Transcription Factors/metabolism
KW - Hyperglycemia/etiology
KW - Cadherins/metabolism
KW - Biomarkers
KW - Cell Line, Tumor
KW - Epithelial-Mesenchymal Transition/drug effects
KW - Protein Binding
KW - Glucose/metabolism
KW - HEAT-SHOCK-PROTEIN-70
KW - APOPTOSIS
KW - ACTIVATION
KW - INVASIVENESS
KW - hyperglycemia
KW - INVASION
KW - PATHWAY
KW - CANCER METASTASIS
KW - colon cancer
KW - MESENCHYMAL TRANSITION
KW - SHOCK
KW - CARCINOMA
UR - http://www.scopus.com/inward/record.url?scp=85108655813&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/1fa97c50-dc63-367b-8427-e90e38abc11a/
U2 - 10.3390/ijms22136902
DO - 10.3390/ijms22136902
M3 - Article
C2 - 34199046
VL - 22
JO - International Journal of Molecular Sciences
JF - International Journal of Molecular Sciences
SN - 1422-0067
IS - 13
M1 - 6902
ER -
ID: 84853486